Yahoo Web Search

Search results

  1. June 10, 2021, 12:57 PM PDT. By Erika Edwards. A higher-than-usual number of cases of a type of heart inflammation has been reported following Covid-19 vaccination, especially among young men ...

  2. Jan 20, 2023 · No evidence indicates that the Pfizer-BioNTech and Moderna mRNA COVID-19 vaccines are associated with the same risk of blood clots. However, data from multiple studies show a slight risk for myocarditis and pericarditis following the mRNA COVID-19 vaccines. These cases occurred most frequently in males, ages 16 years and older, within seven ...

  3. May 3, 2024 · Soon after their arrival in late December 2020, the Covid-19 vaccines turned the pandemic around and opened a path back to normalcy. They prevented about 14.4 million deaths worldwide, according ...

  4. Feb 8, 2023 · He had heart failure as a result of myocarditis after the second dose of an inactivated COVID-19 vaccine. 45 Other studies reported no myocarditis incidence in a subject receiving inactivated COVID-19 vaccine. 126, 127 A population-based study also showed that mainly, two mRNA vaccines mRNA-1273 (Moderna) & BNT162b2 (Pfizer-BioNTech) were more ...

  5. Jan 3, 2023 · The IRR arrhythmia post-Pfizer or Moderna COVID-19 vaccines was 5.5-times and 19-times higher than the IRR of arrhythmia post-AstraZeneca vaccine. Similarly, the pooled RR showed that the Pfizer vaccine had a non-significantly higher RR compared to AstraZeneca (RR = 1.63, 95% CI: 0.77 to 3.46; Figure 3 ).

  6. Oct 3, 2023 · Yes. The CDC says a COVID-19 vaccine and other immunizations, such as a flu shot, can be given together, or without any specific time interval in between. The agency recommends almost everyone 6 months and older be vaccinated against flu annually, ideally in September or October.

  7. Apr 9, 2020 · Pfizer and BioNTech to jointly develop COVID-19 vaccine, initially in the United States and Europe, and scale-up manufacturing capacity to support global supply Potential to supply millions of vaccine doses by the end of 2020 subject to technical success of the development program and approval by regulatory authorities, and then rapidly scale up capacity to produce hundreds of millions of ...